BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36561345)

  • 1.
    Wei J; Wang X; Dong Y; Zhong X; Ren X; Song R; Ma J; Yu A; Fan Q; Yao J; Shan D; Lv F; Zheng Y; Deng Q; Li X; He Y; Fan S; Zhao C; Wang X; Yuan R; She G
    Front Pharmacol; 2022; 13():1027687. PubMed ID: 36561345
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumor activity and linear-diarylheptanoids of herbal couple Curcumae Rhizoma-Sparganii Rhizoma and the single herbs.
    Chang YL; Xu GL; Wang XP; Yan X; Xu X; Li X; Chen ZK; Ren X; Chen XQ; Zhang JH; Wang XH; Ren XY; Liu XY; Wang Y; Sun SQ; Li X; She GM
    J Ethnopharmacol; 2020 Mar; 250():112465. PubMed ID: 31821851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active ingredients screening and pharmacological mechanism research of curcumae rhizoma-sparganii rhizoma herb pair ameliorates liver fibrosis based on network pharmacology.
    Hao M; Yao Z; Zhao M; Chen Z; Wang P; Sang X; Yang Q; Wang K; Han X; Cao G
    J Ethnopharmacol; 2023 Apr; 305():116111. PubMed ID: 36592822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Composition, Antioxidative and Anticancer Activities of the Essential Oil: Curcumae Rhizoma-Sparganii Rhizoma, a Traditional Herb Pair.
    Xu GL; Geng D; Xie M; Teng KY; Tian YX; Liu ZZ; Yan C; Wang Y; Zhang X; Song Y; Yang Y; She GM
    Molecules; 2015 Aug; 20(9):15781-96. PubMed ID: 26343630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated approach to uncover anti-tumor active materials of Curcumae Rhizoma-Sparganii Rhizoma based on spectrum-effect relationship, molecular docking, and ADME evaluation.
    Liu XY; Chang YL; Wang XH; Wang Y; Ren XY; Ma JM; Yu AX; Wei J; Fan QQ; Dong Y; Song RL; Yao JL; Shan DJ; She GM
    J Ethnopharmacol; 2021 Nov; 280():114439. PubMed ID: 34293455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the mechanism of action of Sparganii Rhizoma-Curcumae Rhizoma for in treating castration-resistant prostate cancer: a network-based pharmacology and experimental validation study.
    Wu L; Chen H; Long Y; Qiu J; Dai X; You X; Li T
    Sci Rep; 2024 Feb; 14(1):3099. PubMed ID: 38326539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of curcumae rhizoma-sparganii rhizoma medicated serum in epithelial-mesenchymal transition in the triple negative breast cancer: Pharmacological role of CR-SR in the TBNC.
    Yin Y; Feng L; Wang L; Ding L
    Biomed Pharmacother; 2018 Mar; 99():340-345. PubMed ID: 29358127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS.
    Lan Z; Zhang Y; Sun Y; Wang L; Huang Y; Cao H; Wang S; Meng J
    Front Pharmacol; 2021; 12():769021. PubMed ID: 34955839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
    Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
    Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-colorectal cancer mechanism of Astragali Radix-Curcumae Rhizoma-Paridis Rhizoma based on network pharmacology and experimental verification].
    Liang Y; Sun RL; Liu FY; Liu TT; Guan HQ; Tang DC
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):776-785. PubMed ID: 35178961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated serum and urinary metabonomic research of Rhizoma Curcumae-Rhizoma Sparganii drug pair in hysteromyoma rats based on UPLC-Q-TOF-MS analysis.
    Li W; Hong B; Li Q; Li Z; Bi K
    J Ethnopharmacol; 2019 Mar; 231():374-385. PubMed ID: 30476536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the Molecular Mechanism of the Herbal Couple Sparganii Rhizoma-Curcumae Rhizoma in the Treatment of Lung Cancer Based on Network Pharmacology.
    Dai S; Zhang G; Zhao F; Shu Q
    Evid Based Complement Alternat Med; 2021; 2021():6664489. PubMed ID: 34239587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the molecular mechanisms of Curcumae Rhizoma against myocardial fibrosis using network pharmacology and experimental validation.
    Zhang M; Lu P; Zhao F; Sun X; Ma W; Tang J; Zhang C; Ji H; Wang X
    J Ethnopharmacol; 2023 Jan; 300():115751. PubMed ID: 36162550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on intervention effect of Astragali Radix-Curcumae Rhizoma on growth and metastasis of colon cancer in orthotopic transplantation mice model of colon cancer].
    Sun RL; Tang DC; Gu JF
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2267-2275. PubMed ID: 34047130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of material basis and mechanism of Curcumae Rhizoma in treatment of coronary heart disease].
    Fei CH; Tong HJ; Li Y; Xu Z; Qin YW; Bian ZH; Su LL; Ji D; Lu TL; Mao CQ
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3270-3284. PubMed ID: 35851121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism and material basis of Sparganii Rhizoma and vinegar-processed Sparganii Rhizoma in treatment of hyperlipidemia based on network pharmacology].
    Zhang T; Liu HH; Yu YP; Wang M; Ji D; Su LL; Lu TL; Li L
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2767-2777. PubMed ID: 35718497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative Effects of Component Chinese Medicine From
    Zhang L; Xu Q; Li Y; Zhao H; Shi X; Peng F; Yu C
    Front Public Health; 2021; 9():674357. PubMed ID: 34123993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of multiple representative components in the herb pair Astragali Radix-Curcumae Rhizoma and its single herbs by UPLC-QQQ-MS.
    Yin G; Cheng X; Tao W; Dong Y; Bian Y; Zang W; Tang D
    J Pharm Biomed Anal; 2018 Jan; 148():224-229. PubMed ID: 29055246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Comparisons of Typical Constituents in
    Gu W; Li JC; Ji D; Li L; Zhang J; Pan ZH; Yang JJ; Lu TL; Mao CQ
    Evid Based Complement Alternat Med; 2018; 2018():6809497. PubMed ID: 29725355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparganii Rhizoma: A review of traditional clinical application, processing, phytochemistry, pharmacology, and toxicity.
    Jia J; Li X; Ren X; Liu X; Wang Y; Dong Y; Wang X; Sun S; Xu X; Li X; Song R; Ma J; Yu A; Fan Q; Wei J; Yan X; Wang X; She G
    J Ethnopharmacol; 2021 Mar; 268():113571. PubMed ID: 33181282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.